Clinical Trial

A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

Name: A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia — clinical trial record (NCT07695597)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-parallel, multicenter phase II clinical trial to evaluate the efficacy and safety of SYH2070 injection in participants with mixed hyperlipidemia.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-23

Trial Details

NCT Number	NCT07695597
Lead Sponsor	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Conditions	Mixed Hyperlipidemia
Enrollment	240 participants
Start Date	2026-07-15
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-09-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-22